The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Nature Medicine2000Vol. 6(9), pp. 1004–1010
Citations Over TimeTop 1% of 2000 papers
Yasuko Kureishi, Zhengyu Luo, Ichiro Shiojima, Ann Bialik, David Fulton, David J. Lefer, William C. Sessa, Kenneth Walsh
Related Papers
- → Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy(2012)79 cited
- → Lower levels of Caveolin-1 and higher levels of endothelial nitric oxide synthase are observed in abdominal aortic aneurysm patients treated with simvastatin(2018)17 cited
- → Simvastatin ameliorates vascular endothelial growth factor overexpression in a rat model of diabetic retinopathy: a histological and immunohistochemical study(2017)1 cited
- → e0044 The role of Ang1 and eNOS in the proangiogenic effect of simvastatin after myocardial infarction in rats(2010)
- The proangiogenic effect of simvastatin on experimental myocardial infarction of rats(2010)